KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $4.0 billion.

  • Gilead Sciences' Free Cash Flow fell 496.64% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 billion, marking a year-over-year decrease of 285.23%. This contributed to the annual value of $10.3 billion for FY2024, which is 3886.27% up from last year.
  • Per Gilead Sciences' latest filing, its Free Cash Flow stood at $4.0 billion for Q3 2025, which was down 496.64% from $720.0 million recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Free Cash Flow peaked at $4.2 billion during Q3 2024, and registered a low of $720.0 million during Q2 2025.
  • In the last 5 years, Gilead Sciences' Free Cash Flow had a median value of $2.2 billion in 2021 and averaged $2.3 billion.
  • Within the past 5 years, the most significant YoY rise in Gilead Sciences' Free Cash Flow was 15523.58% (2024), while the steepest drop was 4565.71% (2024).
  • Quarter analysis of 5 years shows Gilead Sciences' Free Cash Flow stood at $3.0 billion in 2021, then fell by 21.74% to $2.4 billion in 2022, then decreased by 18.11% to $2.0 billion in 2023, then skyrocketed by 44.73% to $2.8 billion in 2024, then surged by 40.06% to $4.0 billion in 2025.
  • Its Free Cash Flow stands at $4.0 billion for Q3 2025, versus $720.0 million for Q2 2025 and $1.7 billion for Q1 2025.